RT Journal Article
SR Electronic
T1 The impact of SARS-CoV-2 transmission fear and COVID-19 pandemic on the mental health of patients with primary immunodeficiency disorders, severe asthma, and other high-risk groups
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.26.20140616
DO 10.1101/2020.06.26.20140616
A1 Çölkesen, Fatih
A1 Kılınçel, Oğuzhan
A1 Sözen, Mehmet
A1 Yıldız, Eray
A1 Beyaz, Şengül
A1 Çölkesen, Fatma
A1 Aytekin, Gökhan
A1 Koçak, Mehmet Zahid
A1 Alsancak, Yakup
A1 Araz, Murat
A1 Arslan, Şevket
YR 2020
UL http://medrxiv.org/content/early/2020/06/28/2020.06.26.20140616.abstract
AB Background The adverse effects of COVID-19 pandemic on the mental health of high-risk group patients for morbidity and mortality and its impact on public health in the long term have not been clearly determined.Objective To determine the level of COVID-19 related transmission fear and anxiety in healthcare workers and patients with primary immunodeficiency disorder (PID), severe asthma, and the ones with other comorbidities.Methods The healthcare workers and patients with PID, severe asthma (all patients receiving biological agent treatment), malignancy, cardiovascular disease, hypertension (90% of patients receiving ACEI or ARB therapy), diabetes mellitus (42 % of patients receiving DPP-4 inhibitor therapy) were included in the study. A total of 560 participants, 80 individuals in each group, were provided. The hospital anxiety and depression scale (HADS) and Fear of illness and virus evaluation (FIVE) scales were applied to the groups with face to face interview methods.Results The mean age was 49.30 ± 13.74 years and 306 (55 %) were female. The FIVE Scale and HADS-A scale scores of health care workers were significantly higher than other groups scores (p = 0.001 and 0.006). The second-highest scores belonged to patients with PID. There was no significant difference between the groups for the HADS-D score (p=0.07). The lowest score in all scales was observed in patients with hypertension.Conclusions This study demonstrated that in the pandemic process, patients with primary immunodeficiency, asthma patients, and other comorbid patients, especially healthcare workers, should be referred to the centers for the detection and treatment of mental health conditions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee of Necmettin Erbakan University, Meram Faculty of Medicine with the 2020/2448 ID number, and the study was conducted according to the 1975 Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available.ACEIAngiotensin converting enzyme inhibitorsARBAngiotensin II receptor blockerARDSAcute respiratory distress syndromeAUCArea under the curveCIConfidence intervalCOVID-19Coronavirus disease 2019CIDCombined immunodeficiencyCVIDCommon variable immune deficiencyCVSCardiovascular systemDMDiabetes mellitusDPP-4Dipeptidyl peptidase-4FIVEFear of illness and virus evaluationHADSHospital anxiety and depression scaleHADS-AHospital anxiety and depression scale, anxiety subscaleHADS-DHospital anxiety and depression scale, depression subscaleHCCHepatocellular carcinomaHTHypertensionNKNatural killerPIDPrimary immunodeficiency disorderSARS-CoV-2Severe acute respiratory syndrome coronavirus-2SCIGSubcutaneous immunoglobulin